Author

G Makharia

Professor of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences - Cited by 12,967 - Gastroenterology

Biography

Dr. Govind K. Makharia is currently working as a Professor in the Department of Internal Medicine, All India Institute Of Medical Sciences , India. His research interests includes Internal Medicine. He /she is serving as an editorial member and reviewer of several international reputed journals. Dr. Govind K. Makharia is the member of many international affiliations. He/ She has successfully completed his Administrative responsibilities. He /she has authored of many research articles/books related to Internal Medicine.
Title
Cited by
Year
Third Asia-Pacific consensus recommendations on colorectal cancer screening and postpolypectomy surveillance
JJY Sung, HM Chiu, D Lieberman, EJ Kuipers, MD Rutter, F Macrae, ...Gut 71 (), 2152-2166, 2022202
11
2022
Long-term gastrointestinal sequelae following COVID-19: A prospective follow-up cohort study
R Golla, S Vuyyuru, B Kante, P Kumar, DM Thomas, G Makharia, S Kedia, ...Clinical Gastroenterology and Hepatology 21 (3), 789-796. e1, 2023202
10
2023
Who to screen and how to screen for celiac disease
P Singh, AD Singh, V Ahuja, GK MakhariaWorld Journal of Gastroenterology 28 (32), 4493, 2022202
7
2022
Minimal risk of lymphoma and non‐melanoma skin cancer despite long‐term use of thiopurines in patients with inflammatory bowel disease: A longitudinal cohort analysis from …
MK Ranjan, B Kante, SK Vuyyuru, P Kumar, SK Mundhra, R Golla, ...Journal of Gastroenterology and Hepatology 37 (8), 144-13, 2022202
5
2022
Inflammatory and deleterious role of gut microbiota-derived trimethylamine on colon cells
R Jalandra, GK Makharia, M Sharma, A KumarFrontiers in Immunology 13, 110149, 030
2
2023
Relapse rates after withdrawal of thiopurines in patients with inflammatory bowel disease
MK Ranjan, SK Vuyyuru, B Kante, P Kumar, SK Mundhra, R Golla, ...International Journal of Colorectal Disease 37 (8), 1817-186, 0
2
2022
High seroprevalence against SARS-Cov-2 in non-vaccinated patients with inflammatory bowel disease from Northern India
High seroprevalence against SARS-Cov- in non-vaccinated patients with inflammatory bowel disease from Northern IndiaB Kante, SK Vuyyuru, R Gupta, T Dwivedi, P Kumar, S Mundhra, R Golla, ...Indian Journal of Gastroenterology 4 (1), 70-78, 030
2
2023
Patterns of practice in the diagnosis, dietary counselling and follow-up of patients with celiac disease—A patient-based survey
W Mehtab, H Agarwal, T Ghosh, A Chauhan, A Ahmed, A Singh, N Vij, ...Indian Journal of Gastroenterology 4 (1), 88-95, 030
2
2023
Prevalence of celiac disease in patients with liver diseases: A systematic review and meta-analyses
S Yoosuf, P Singh, A Khaitan, TA Strand, V Ahuja, GK MakhariaThe American Journal of Gastroenterology 118 (5), 80-83, 030
2
2023
Efficacy and safety of biosimilar versus originator infliximab in patients with inflammatory bowel disease: A real-world cohort analysis
P Kumar, SK Vuyyuru, B Kante, S Kedia, P Sahu, MK Ranjan, S Mundhra, ...Indian Journal of Gastroenterology 4 (5), 446-455, 2022202
1
2022
Low prevalence of Clostridioides difficile infection in acute severe ulcerative colitis: A retrospective cohort study from northern India
S Mundhra, D Thomas, S Jain, P Sahu, S Vuyyuru, P Kumar, B Kante, ...Indian Journal of Gastroenterology, -7, 2023202
1
2023
Thromboembolism is associated with poor prognosis and high mortality in patients with inflammatory bowel disease: A case–control study
S Kedia, V Teja, SK Vuyyuru, N Yadav, P Sahu, S Jain, DP Yadav, ...Indian Journal of Gastroenterology 4 (4), 325-335, 2022202
1
2022
Monotherapy with thiopurines in stricturing Crohn’s disease: A real-life experience from low-and middle-income countries
B Kante, SK Vuyyuru, S Kedia, P Sahu, P Kumar, MK Ranjan, S Virmani, ...Indian Journal of Gastroenterology 4 (4), 343-35, 2022202
1
2022